78 related articles for article (PubMed ID: 7994252)
1. Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation.
Ferster A; Bujan W; Mouraux T; Devalck C; Heimann P; Sariban E
Bone Marrow Transplant; 1994 Aug; 14(2):331-2. PubMed ID: 7994252
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
Sanz Rodríguez C; Steegmann JL; Granda A; de la Cámara R; Figuera A; Arranz R; Gómez-García de Soria V; Alegre A; Fernández-Rañada JM
Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study.
Choi SJ; Lee JH; Lee JH; Kim S; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Jang S; Park CJ; Chi HS; Lee KH
Bone Marrow Transplant; 2005 Jul; 36(2):163-9. PubMed ID: 15937507
[TBL] [Abstract][Full Text] [Related]
6. Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion.
Yazaki M; Andoh M; Ito T; Ohno T; Wada Y
Bone Marrow Transplant; 1997 Feb; 19(4):393-4. PubMed ID: 9051252
[TBL] [Abstract][Full Text] [Related]
7. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
Verdonck LF; Petersen EJ; Lokhorst HM; Nieuwenhuis HK; Dekker AW; Tilanus MG; de Weger RA
Bone Marrow Transplant; 1998 Dec; 22(11):1057-63. PubMed ID: 9877267
[TBL] [Abstract][Full Text] [Related]
8. Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients.
Russell LA; Jacobsen N; Heilmann C; Simonsen AC; Christensen LD; Vindelov LL
Bone Marrow Transplant; 1996 Aug; 18(2):411-4. PubMed ID: 8864454
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplant indications for childhood leukemias: achieving a consensus. The EBMT Pediatric Diseases Working Party.
Dini G; Cornish JM; Gadner H; Souillet G; Vossen JM; Paolucci P; Manfredini L; Miano M; Niethammer D
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():4-7. PubMed ID: 8932789
[TBL] [Abstract][Full Text] [Related]
10. Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation.
van der Griend R; Verdonck LF; Petersen EJ; Veenhuizen P; Bloem AC; Lokhorst HM
Bone Marrow Transplant; 1999 Jan; 23(2):195-7. PubMed ID: 10197809
[TBL] [Abstract][Full Text] [Related]
11. Donor leukocyte infusion after allogeneic bone marrow transplantation was not effective for relapsed rhabdomyosarcoma.
Moritake H; Ikuno Y; Tasaka H; Koga H; Miyazaki S; Okamura J
Bone Marrow Transplant; 1998 Apr; 21(7):725-6. PubMed ID: 9578314
[TBL] [Abstract][Full Text] [Related]
12. Donor leukocyte infusion as salvage therapy in an adult with relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation.
Chang CS; Lin SF; Liu TC; Huang SM; Chen TP
J Formos Med Assoc; 1998 Jan; 97(1):55-8. PubMed ID: 9481066
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse.
Miglino M; Berisso G; Grasso R; Canepa L; Clavio M; Pierri I; Pietrasanta D; Gatto S; Varaldo R; Ballerini F; Verdiani S; Casarino L; DeStefano F; Sessarego M; Dominietto A; Raiola AM; Bregante S; di Grazia C; Gobbi M; Bacigalupo A
Bone Marrow Transplant; 2002 Nov; 30(9):579-85. PubMed ID: 12407432
[TBL] [Abstract][Full Text] [Related]
14. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
[TBL] [Abstract][Full Text] [Related]
15. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
16. Successful donor leukocyte infusion for chronic myeloid leukemia relapsing in accelerated phase after T cell-replete unrelated marrow transplantation.
Grigg A; Szer J
Bone Marrow Transplant; 1996 Sep; 18(3):647-8. PubMed ID: 8879633
[TBL] [Abstract][Full Text] [Related]
17. Donor leukocyte infusions in acute lymphocytic leukemia.
Collins RH; Goldstein S; Giralt S; Levine J; Porter D; Drobyski W; Barrett J; Johnson M; Kirk A; Horowitz M; Parker P
Bone Marrow Transplant; 2000 Sep; 26(5):511-6. PubMed ID: 11019840
[TBL] [Abstract][Full Text] [Related]
18. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
[TBL] [Abstract][Full Text] [Related]
19. [The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].
Schattenberg AV; van de Wiel-van Kemenade E; Bär BM; Geurts van Kessel AH; van der Maazen RW; de Witte TJ
Ned Tijdschr Geneeskd; 1996 Oct; 140(42):2087-91. PubMed ID: 8965951
[TBL] [Abstract][Full Text] [Related]
20. Acute polymyositis after donor lymphocyte infusion.
Lin PC; Hsiao LT; Chen PM
Eur J Haematol; 2005 Feb; 74(2):166-8. PubMed ID: 15654909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
